What is Syntactx?
Syntactx operates within the medical device contract research organization (CRO) sector, specializing in preclinical and clinical research, biological safety testing, and regulatory compliance. The company offers a comprehensive suite of services, including consulting, preclinical research, clinical trials, and medical device testing, aimed at ensuring the global safety and compliance of medical devices. With a team of over 1,400 professionals, Syntactx supports medical device manufacturers across North America, Europe, and Asia, facilitating efficient market entry. Their extensive experience and global reach position them as a key partner for thousands of medical device manufacturers worldwide.
How much funding has Syntactx raised?
Syntactx has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Syntactx?
The recent major strategic investment into Syntactx signals a pivotal moment for the company, likely indicating a move towards scaling operations, expanding service offerings, or enhancing technological capabilities. This infusion of capital, contextualized by the 'major enterprise-level funding' and 'major strategic investment' descriptors, suggests Syntactx is poised for significant growth and potentially entering a new phase of market penetration or innovation. The company's focus on regulatory compliance and safety testing for medical devices, a critical and evolving field, positions it well to leverage this new financing for strategic advancements and increased market share.
See full Syntactx company page
